- $372.79m
- $734.03m
- $1.13bn
- 32
- 94
- 49
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 1,011 | 888 | 1,075 | 1,104 | 1,134 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,013 | 1,078 | 958 | 1,094 | 1,156 |
Operating Profit | -2.11 | -190 | 117 | 9.27 | -22.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -28.8 | -217 | 147 | -6.22 | -39.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1 | -176 | 144 | -0.402 | -38.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 1 | -176 | 144 | -0.402 | -38.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1 | -176 | 144 | -0.402 | -38.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.083 | -1.13 | 1.95 | 0.072 | -0.073 |
Dividends per Share |